EsoBiotec, which has successfully advanced its ESO-T01 in vivo CAR-T candidate into clinical trials. ESO-T01 is the first in vivo B-cell maturation antigen (BCMA) CAR-T candidate to reach the clinical ...
Grand Challenges Canada (GCC), in partnership with the Science for Africa Foundation (SFA Foundation), the Global Grand Challenges Network, and The Geneva Learning Foundation, is proud to announce the ...
Threats to Russia at its western borders must be eliminated, as this is "one of the main causes" of the Ukrainian conflict, Russian Foreign Minister Sergey Lavrov said on January 14 at a press ...